Subsequent Events (Details) - USD ($)				1 Months Ended
	Feb. 13, 2019	Jan. 28, 2019	Jan. 15, 2019	Mar. 31, 2019	Feb. 28, 2019	Jan. 14, 2019	Feb. 07, 2019	Dec. 31, 2018	Dec. 31, 2017
Subsequent Events (Textual)
Common stock shares								85,178,902	72,302,937
Convertible note								$ 1,042,314	$ 811,858
Subsequent Event [Member]
Subsequent Events (Textual)
Definitive agreement, Description			Definitive agreement to acquire Hughes Center for Functional Medicine, P.A. ("HCFM") for $750,000 in cash, $750,000 in shares of Company common stock and $500,000 in a three-year performance-based payout.
Consulting agreement, description		The Company entered into a consulting agreement with an unrelated third party to provide services in exchange for 125,000 shares of Company common stock to be issued at the time of the agreement and up to 375,000 upon achievement of future milestones. During March 2018, the Company issued 250,000 of the shares, including 125,000 due on signing of the agreement and 125,00 upon achievement of the first milestone.
Private placement transaction, description	The investor in the July 18, 2018 private placement transaction exercised the remaining 2,098,427 of the Pre-Funded Warrants. We did not receive any proceeds from the transaction.
Investment agreement, description	Between January 1, 2019 and March 27, 2019, the Company made draws pursuant to the Investment Agreement totaling 1,694,043 shares for proceeds of $404,394.
Subsequent Event [Member] | Common Stock [Member]
Subsequent Events (Textual)
Sale of stock				1,250,000	1,250,000
Share price				$ 0.30	$ 0.30
Proceeds from sales				$ 340,000	$ 340,000
Warrants issued				250,000	250,000
Exercise price				$ 0.50	$ 0.50
Warrants date				3 years	3 years
Subsequent Event [Member] | Warrants [Member]
Subsequent Events (Textual)
Warrants issued				566,667	566,667
Exercise price				$ 0.40	$ 0.40
Warrants date				5 years	5 years
Subsequent Event [Member] | $78k Note [Member]
Subsequent Events (Textual)
Securities purchase agreement maturity date						Oct. 14, 2019
Sale of convertible note						$ 78,000
Fee for net proceeds						3,000
Net proceeds						$ 75,000
Interest rate						10.00%
Default interest rate						22.00%
Beneficial ownership, percentage						4.99%
Conversion price per share, percentage						25.00%
Outstanding principal and any interest, percentage						300.00%
Outstanding principal and any interest in default, percentage						150.00%
Common stock shares						28,000
Subsequent Event [Member] | $171.5k Note [Member]
Subsequent Events (Textual)
Common stock shares							2,512,821
Convertible note							$ 171,500